# ReShape Lifesciences, Inc. – FDA Inspection, Nov 25, 2013

Source: https://www.keypedia.com/records/fda_inspections/reshape-lifesciences-inc/990239b7-09ea-419b-9b89-911122298ba3
Source feed: FDA_Inspections

> FDA inspection 856112 of ReShape Lifesciences, Inc., November 25, 2013. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 812. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 856112
- Company Name: ReShape Lifesciences, Inc.
- Inspection Date: 2013-11-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 2

## Related Documents

- [FDA Inspection 1091756 - 2019-05-22](https://www.keypedia.com/records/fda_inspections/reshape-lifesciences-inc/e4e54b6b-de8f-410c-9f4c-67b3c01d41f9)
- [FDA Inspection 1036574 - 2017-12-18](https://www.keypedia.com/records/fda_inspections/reshape-lifesciences-inc/feb5d6d2-62f7-407c-accc-83f1f06b20bc)
- FDA Inspection 974242 - 2016-04-22
- FDA Inspection 838101 - 2013-06-17

Company: https://www.keypedia.com/companies/reshape-lifesciences-inc/740415bf-ee64-46b0-91ff-3ff435f3769d

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7
